Overactive bladder OAB
Conditions
Interventions
Double-blind randomized placebo controlled trial
Sponsors
Fukata Satoshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All of the following criteria must be met in order to participate in this trial. 1.Patients with overactive bladder over 30 years old 2.Patients with overactive bladder who consented to participate in the study in writing
Exclusion criteria
Exclusion criteria: If any of the following criteria are met, the patient will not be allowed to participate in this trial. 1.Patients with organic disease of the urinary tract 2.Patients with neurogenic overactive bladder 3.Patients with malignant tumors of the urinary sys tem 4.Patients with cognitive dysfunction or psychiatri c disorders that are difficult to conduct research 5.Patients who are allergic to 5-ALA 6.Patients with porphyria 7.Patients with drug hypersensitivity such as iron a llergy 8.Pregnant women or patients who may become p regnant 9.Patients who did not consent to participate in th e study in writing 10.Patients disqualified by a doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OABSS (Amount of change from baseline in OABSS after 12 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) OABSS (Amount of change from baseline in OA BSS after 4 weeks) (2) Change in residual urine volume from baseline (3) Amount of change from baseline in OABq-SF | — |
Contacts
Public ContactSatoshi Fukata
Kochi Medical School Hospital
Outcome results
None listed